Literature DB >> 16234968

Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men.

Patricia Crabbe1, Wendy Balemans, Andy Willaert, Inge van Pottelbergh, Erna Cleiren, Paul J Coucke, Minrong Ai, Stefan Goemaere, Wim van Hul, Anne de Paepe, Jean-Marc Kaufman.   

Abstract

UNLABELLED: We studied whether the LRP5 gene contributes to the clinical phenotype of IO in men. Mutation analysis in 66 IO men revealed a range of sequence variants, of which two missense variants were shown to be of functional relevance.
INTRODUCTION: Mutations in the LDL receptor-related protein 5 (LRP5) gene have been associated with extreme bone phenotypes, which makes LRP5 a plausible candidate gene for idiopathic osteoporosis (IO).
MATERIALS AND METHODS: In 66 men with IO, all 23 exons and exon-intron boundaries of the LRP5 gene were screened for mutations, and functional analyses were performed for those that were putatively involved in the phenotype.
RESULTS: Mutation analysis in the IO probands revealed five missense mutations, of which 1067C>T (S356L), 1364C>T (S455L), and 4609G>A (A1537T) were of potential functional significance because they were located in highly conserved regions of LRP5 and not found in a control panel. Segregation analysis in the respective families could not exclude their possible causality for IO. Furthermore, functional analyses clearly showed an inhibitory effect of mutations 1067C>T and 1364C>T on Wnt signal transduction. These effects are most likely caused by impaired LRP5 synthesis in the case of 1067C>T and failure of protein trafficking to the cell surface for 1364C>T.
CONCLUSIONS: For 2 of 66 IO probands, a mutation in the LRP5 gene with proven functionality was found. The findings indicate that carrying an LRP5 mutation is a risk factor for IO, but that overall, IO in men is infrequently underlied by such a mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234968     DOI: 10.1359/JBMR.050705

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

Review 1.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

Review 2.  Idiopathic osteoporosis in men.

Authors:  Luigi Gennari; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

3.  LRP5 gene polymorphism and cortical bone.

Authors:  Fulvio Lauretani; Chiara Cepollaro; Stefania Bandinelli; Antonio Cherubini; Alessia Gozzini; Laura Masi; Alberto Falchetti; Francesca Del Monte; Silvia Carbonell-Sala; Francesca Marini; Annalisa Tanini; Anna Maria Corsi; Gian Paolo Ceda; Maria Luisa Brandi; Luigi Ferrucci
Journal:  Aging Clin Exp Res       Date:  2010-08       Impact factor: 3.636

4.  Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.

Authors:  Douglas P Kiel; Serge L Ferrari; L Adrienne Cupples; David Karasik; Danielle Manen; Alma Imamovic; Alan G Herbert; Josée Dupuis
Journal:  Bone       Date:  2006-11-28       Impact factor: 4.398

5.  Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).

Authors:  C M Laine; B D Chung; M Susic; T Prescott; O Semler; T Fiskerstrand; P D'Eufemia; M Castori; M Pekkinen; E Sochett; W G Cole; C Netzer; O Mäkitie
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

6.  Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.

Authors:  Johanna Korvala; Harald Jüppner; Outi Mäkitie; Etienne Sochett; Dirk Schnabel; Stefano Mora; Cynthia F Bartels; Matthew L Warman; Donald Deraska; William G Cole; Heini Hartikka; Leena Ala-Kokko; Minna Männikkö
Journal:  BMC Med Genet       Date:  2012-04-10       Impact factor: 2.103

Review 7.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

8.  Ocular Features and Mutation Spectrum of Patients With Familial Exudative Vitreoretinopathy.

Authors:  Tianchang Tao; Ningda Xu; Jiarui Li; Hongyan Li; Jinfeng Qu; Hong Yin; Jianhong Liang; Mingwei Zhao; Xiaoxin Li; Lvzhen Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

9.  Primary Osteoporosis in Young Adults: Genetic Basis and Identification of Novel Variants in Causal Genes.

Authors:  Corinne Collet; Agnès Ostertag; Manon Ricquebourg; Marine Delecourt; Giulia Tueur; Bertrand Isidor; Pascale Guillot; Elise Schaefer; Rose-Marie Javier; Thomas Funck-Brentano; Philippe Orcel; Jean-Louis Laplanche; Martine Cohen-Solal
Journal:  JBMR Plus       Date:  2017-11-06

10.  Comprehensive Genetic Analysis of 128 Candidate Genes in a Cohort With Idiopathic, Severe, or Familial Osteoporosis.

Authors:  Manuela G M Rocha-Braz; Monica M França; Adriana M Fernandes; Antonio M Lerario; Evelin A Zanardo; Lucas S de Santana; Leslie D Kulikowski; Regina M Martin; Berenice B Mendonca; Bruno Ferraz-de-Souza
Journal:  J Endocr Soc       Date:  2020-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.